Lumos Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lumos board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lumos Board Today - Breaking & Trending Today

Lumos Diagnostics Appoints Three Industry Leaders as Independent Directors

Press release content from Business Wire. The AP news staff was not involved in its creation.
Lumos Diagnostics Appoints Three Industry Leaders as Independent Directors
May 5, 2021 GMT
SARASOTA, Fla. (BUSINESS WIRE) May 5, 2021
Lumos Diagnostics announced today the expansion of its board with the appointment of three new independent directors to support the continued growth of the company’s rapid point-of-care diagnostic products and services business. Bronwyn Le Grice, Lawrence Mehren and Catherine Robson will join Executive Chair Sam Lanyon and and Executive Director Rob Sambursky, MD.
“On behalf of the entire company, I am delighted to welcome Bronwyn, Larry and Catherine to the Lumos Board of Directors,” said Sam Lanyon, executive chair of Lumos Diagnostics. “Together, they offer extensive and diverse operational experience in growing diagnostic companies, strong knowledge of equity markets and broad corporate governance expertise. Lumos will benef ....

Rob Sambursky , Lawrence Mehren , Bronwyn Le Grice , Cristina Fletcher , Le Grice , Catherine Robson , Sam Lanyon , Laura Lovejoy Sambursky , Equity Trust Limited , Ventana Medical Systems Inc , Board Risk Committee , Nominations Committee , We Communications Australia , Greater Bank , Executive Chair Sam Lanyon , Executive Director Rob Sambursky , Lumos Board , Chief Executive Officer , Accelerate Diagnostics , Senior Vice President , Chief Financial Officer , Ventana Medical Systems , Global Business , Affinity Private , Risk Committee , Board Remuneration ,

Lumos Pharma Announces Changes to its Board of Directors

Share:
AUSTIN, Texas, Feb. 16, 2021 (GLOBE NEWSWIRE) Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced the appointment of An van Es-Johansson, M.D., to its Board of Directors, effective immediately, where she will serve as a member of the Nominating and Governance Committee. Dr. van Es-Johansson brings over 30 years of experience in executive and clinical development roles in the pharmaceutical industry. Dr. van Es-Johansson will succeed Emmett Cunningham who is resigning his Board position to focus on other professional obligations in his managerial role at Blackstone Life Sciences.
We are excited to welcome Dr. An van Es-Johansson to our Board, said Rick Hawkins, CEO, President and Chairman. Dr. van Es-Johansson s clinical and corporate experience focused on growth hormone disorders and other rare diseases will be of immense value to Lumos Pharma as we pursue our clinical and business ....

United States , Erick Hawkins , Uppsala Bio , Eli Lily , Alzecure Pharma , Lisa Miller , Emmett Cunningham , Lumos Pharma , Governance Committee , Lumos Pharma Inc , Savara Pharmaceuticals , Company Annual Report On Form , Enterprise Associates , Erasmus University , Roche Venture Fund , Head Of Development , Blackstone Life Sciences , Blackstone Life , Lumos Pharma Board , Lumos Board , Chief Medical Officer , Senior Advisor , Turner Syndrome , Active Biotech , Scientific Advisory , Deerfield Management ,